How Can Telehealth Clinics Advertise Compounded Semaglutide & GLP-1 Weight Loss Ads Compliantly in 2026?
Regulatory standards, FDA 503A compounding rules, and Meta/Google ad guidelines for Semaglutide, Tirzepatide, and weight management telehealth funnels.
- Trademark Infringement (Immediate Ban)
- Absolute Outcome Claims (Ad Disapproval)